FDAnews
www.fdanews.com/articles/203224-amalgam-rxs-insulin-titration-app-isage-rx-awarded-ce-mark

Amalgam Rx’s Insulin Titration App iSage Rx Awarded CE Mark

June 18, 2021

Wilmington, Del.-based Amalgam Rx has received the CE mark for its insulin titration medical device software application, iSage Rx.

In early clinical studies, the iSage Rx app demonstrated the ability to improve patients’ glucose levels by helping them reach the appropriate level of basal insulin, the company said.

The iSage Rx software supports the administration of long-acting insulin doses and is connectable to Bluetooth-enabled blood glucose meters made by Roche, Lifescan and Ascensia.

View today's stories